Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Living proof of transformation
2012-07-20

 Prof. Pumla Gobodo-Madikizela (middle) facilitated a dialogue with Archbishop Emeritus Desmond Tutu and Prof. Mark Solms on the Transformation in the Solms-Delta Wine Estate.
Photo: Johan Roux

18 July 2012

“We have the capacity to make a success of South Africa. We have incredible people who refuse to leave the country and want to make a difference.” This is according to Archbishop Emeritus Desmond Tutu who was speaking at the University of the Free State (UFS) today.

Dr Tutu took part in a dialogue with Prof. Mark Solms, owner of the Solms-Delta wine estate in Franschhoek.Prof. Solms is also an A-rated scholar and the Head of the Department of Psychology at the University of Cape Town.The theme of the dialogue was “Living Reconciliation: Winds of Change in Franschhoek and Transformation at Solms-Delta Wine Estate”.

Prof. Solms led an initiative to transform the lives of farm workers on the estate through the Wijn-de Caab Trust. This initiative was extended to empower the wider community of farm dwellers when Prof. Solms co-founded the Delta Trust and the Franschhoek Valley Transformation Charter.

The dialogue was the second in the Dialogue between Science and Society series and was facilitated by Prof. Pumla Gobodo-Madikizela, Senior research professor on Trauma, Forgiveness and Reconciliation at the UFS. The Dialogue series aims to inspire new ways of thinking about responsible citizenship. It also highlights the unique and important ways of engaging with the critical issues of social equality, social justice, social transformation and reconciliation in South Africa.This morning Dr Tutu said the work done in the Franschhoek community is proof that people cannot prosper alone if others are also not prospering. “We belong together. Why did it take us so long to realise it? South Africans have the capacity to make South Africa a better place. It is unacceptable that people go hungry and go to school under trees. It is unacceptable that they still have no books in the third term, and that the pass rate is 30%.

“Is this why we struggled, why people died? We want to go to our graves smiling… we will not be allowed peace and stability if we do not attend to the problems.”

Prof. Solms said the miracle of the political transformation did not trickle down to the people. A lot has been done, but much more needs to be done. “It can only be done by us. It is not the government’s responsibility. The way we live as a result of apartheid is that we are a deeply divided society. We must recognise this and do something to change it.”

He encouraged people to think “small”. An individual cannot change the whole country, but the changes in his community are there to see.

Dr Tutu also congratulated the UFS on becoming a truly South African university, recognising the transformation of the past few years.

The dialogue was presented at the Global Leadership Summit that 250 students and academic leaders from 21 international universities are participating in. The summit runs until Friday 20 July 2012.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept